To test whether the augmented antibody responses to HA and NA seen with the co-encapsulated combination adjuvant Lipo-(1V270+2B182C) could provide immunologic protection against infection, the adjuvant was tested in a mouse adapted influenza lethal challenge model (Figure 6). Here, XK is linked to infection.